Evidence map›Paper›PMID 36918902›Full record

ArticlePediatric rheumatology online journal2023

Individual and environmental determinants associated with longer times to access pediatric rheumatology centers for patients with juvenile idiopathic arthritis, a JIR cohort study.

Aurélie Chausset, Céline Lambert, Alexandre Belot, Etienne Merlin, Elvira Cannizzaro, Isabelle Kone-Paut, Claire Ballot, Valérie Devauchelle, Sylvaine Poignant, Raffaella Carlomagno and 13 more

Open access · goldFull text read
In one paragraph

Article in Pediatric rheumatology online journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The inequity of global healthcare in pediatric rheumatology.Best practice & research. Clinical rheumatology · 2024
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 15 institutions in 2 countries.

Aurélie ChaussetCRECHE Unit, INSERM CIC 1405, Department of Pediatrics, CHU Clermont-Ferrand, Clermont-Ferrand, France. achausset@chu-clermontferrand.fr.ORCID http://orcid.org/0000-0001-5266-2389
Céline LambertBiostatistics Unit, DRCI, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Alexandre BelotPediatric Nephrology, Rheumatology, Dermatology, HFME, Hospices Civils de Lyon, National Referee Centre RAISE & INSERM U1111, Lyon University, Lyon, France.
Etienne MerlinCRECHE Unit, INSERM CIC 1405, Department of Pediatrics, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Elvira CannizzaroDepartment of Rheumatology, University Children's Hospital, University of Zurich, Zurich, Switzerland.
Isabelle Kone-PautDepartment of Pediatrics & Pediatric Rheumatology, Centre de référence maladies auto-inflammatoires rares et amylose inflammatoire (CEREMAIA), Bicêtre University, Paris Sud Hospital, Le Kremlin-Bicêtre, France.
Claire BallotPediatric Hematology, Jean-Minjoz Hospital, Besançon, France.
Valérie DevauchelleRheumatology Department, CHU Brest and Brest University, INSERM UMR 1227, Brest, France.
Sylvaine PoignantGeneral Pediatrics, CHU Nantes, Nantes, France.
Raffaella CarlomagnoPediatric Immuno-Rheumatology of Western Switzerland, Department Women-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland.
Anne LohseDepartment of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
Catherine BarbierPediatric Immunology, Albert Michallon Hospital, Grenoble, France.
Véronique DespertDepartment of Pediatrics, CHU Rennes, Rennes, France.
Aurélia CarbasseDepartment of Pediatrics, Hôpital Arnaud de Villeneuve, CHRU Montpellier, Montpellier, France.
Laetitia SparsaRheumatology, CH Mulhouse, Mulhouse, France.
Eva AdankDepartment of Pediatrics, Kantonsspital Graubünden, Chur, Switzerland.
Federica VanoniInstitute of Pediatrics of Southern Switzerland, EOC, Bellinzona, Switzerland.
Héloise ReumauxPediatric Rheumatology, Lille University Hospital, Lille, France.
Pascal PilletDepartment of Pediatrics, Hôpital des Enfants, CHRU Bordeaux, Bordeaux, France.
Daniela KaiserDepartment of Pediatrics, Centre Hospitalier Cantonal Luzern, Lucerne, Switzerland.
Michael HoferPediatric Immuno-Rheumatology of Western Switzerland, Department Women-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland.
Caroline Freychet *Research on Healthcare Performance (RESHAPE), INSERM U1290, Claude Bernard University Lyon 1, Lyon, France.
Anne-Marie Schott *Research on Healthcare Performance (RESHAPE), INSERM U1290, Claude Bernard University Lyon 1, Lyon, France.
Inserm · FRUniversité Claude Bernard Lyon 1 · FRUniversity Hospital of Geneva · CHCentre de Référence des Maladies Autoinflammatoires et des Amyloses · FRCentre Hospitalier de Mulhouse · FRCentre Hospitalier Universitaire de Rennes · FRHôpital Albert Michallon · FRHôpital Arnaud de Villeneuve · FRHôpital des Enfants · FRInstitute of Oncology Research · CHKantonsspital Graubünden · CHL'Hôpital Nord Franche-Comté · FRLille’s Cardiology Hospital · FRUniversity of Lucerne · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite guidelines, poor access to appropriate care for juvenile idiopathic arthritis (JIA) patients remains a global issue. Prompt referral to a pediatric rheumatology (PR) center and effective care is known to be critical for changing the natural history of the disease and improving long-term prognosis. This project assesses socio-economic factors of delayed referral to a pediatric rheumatologist (PRst) for JIA patients in France and Switzerland within the Juvenile Inflammatory Rheumatism (JIR) Cohort.

methodsAll patients diagnosed with JIA, presenting at one center of the JIRcohort in France or Switzerland with additional data on referral pathway were included. Patient characteristics at first visit to the PR center, dates of visits to healthcare providers during referral, and parent characteristics were extracted from the JIRcohort database.

resultsTwo hundred fifty children were included. The overall median time to first PR assessment was 2.4 months [1.3; 6.9] and ranged widely across the JIA subtypes, from 1.4 months [0.6; 3.8] for children with systemic juvenile idiopathic arthritis (sJIA) to 5.3 months [2.0; 19.1] for children with enthesitis-related arthritis (ERA). A diagnosis of ERA and an appointment with an orthopedist during the referral pathway were significantly associated with a longer time before the first PR visit (hazard ratio HR 0.50 [95% CI: 0.29; 0.84]) and HR 0.68 [95% CI: 0.49; 0.93], respectively) in multivariable analysis. Having a mother with a post-graduate educational attainment level was tendentially associated with a shorter time before the first PR visit, (HR 1.32 [95% CI: 0.99; 1.78]).

conclusionsTime to first PRst visit was most often short compared to other studies and close to the British recommendations. However, this time remained too long for many patients. We observed no social inequities in access to a PRst, but we show the need to improve effective pathway and access to a PR center for JIA patients.

Indexed as

Arthritis, JuvenileRheumatic FeverTime-to-TreatmentChildChild, PreschoolCohort StudiesFemaleFranceHealth Services AccessibilityHumansMalePrognosisResidence CharacteristicsRheumatologySocioeconomic FactorsSwitzerlandAccess to careJuvenile idiopathic arthritisSocio-economic factorsTime to referral

Identifiers

PMID36918902
PMCPMC10015663
OpenAlexW4324131500

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read89
identifiers read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.